NCT00443768

Brief Summary

To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson's disease is incorrect and to supervise and clinically monitor the withdrawal of anti-parkinson medications in this patient group

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 6, 2007

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
Last Updated

February 4, 2013

Status Verified

February 1, 2013

Enrollment Period

1.8 years

First QC Date

March 2, 2007

Last Update Submit

February 1, 2013

Conditions

Parkinson's Disease

Keywords

MedicationDiagnosisCommunity

Study Arms (2)

1

2

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Community sample of Parkinson's disease patients

You may qualify if:

  • Patients on anti-parkinson medication who:
  • Have been on monotherapy for a prolonged period, or
  • Use anti-parkinson medications intermittently, or
  • Do not have the expected change in medication over time in keeping with degenerative Parkinson's disease.

You may not qualify if:

  • Patients on anti-parkinson medication for reasons other than Parkinson's disease.
  • Patients with significant co-morbidity (end stage liver, cardiac or renal disease).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southern General Hospital

Glasgow, Scotland, G51 4TF, United Kingdom

Location

MeSH Terms

Conditions

Parkinson DiseaseDisease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Donald Grosset, MD

    Dept of Neurology, INS, Southern General Hospital

    STUDY CHAIR

  • Edward Newman, MRCP

    Dept of Neurology, INS, Southern General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Neurologist

Study Record Dates

First Submitted

March 2, 2007

First Posted

March 6, 2007

Study Start

October 1, 2006

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

February 4, 2013

Record last verified: 2013-02

Locations

GB(1)